ARTL
NASDAQ · Pharmaceuticals
Artelo Biosciences Inc
$2.12
-0.16 (-6.83%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+642.3% upside
Low Target
$11.87
Average Target
$15.70
High Target
$22.80
Current Price
$2.12
Current
$2.12
$2.12
Target
$15.70
$15.70
$11.87
$15.70 avg
$22.80
Scenario Analysis
Bear Case
$11.87
461.2%
Low target
Base Case
$15.70
+642.3%
Avg target
Bull Case
$22.80
+978.0%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$179.19
-98.8% from high
52-Week Low
$2.05
+3.2% from low
Target vs 52W High
$15.70
-91.2% vs high
Next Earnings Report
Nov 10, 2026
3d
until earnings
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals